다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Kazia Therapeutics Ltd (KZIA)
Kazia Therapeutics Ltd (KZIA) 뉴스

KZIA

Kazia Therapeutics (KZIA)

Kazia Therapeutics Ltd

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:KZIA

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/24	03:41	PR Newswire (US)	Kazia Granted 180-Day Extension by Nasdaq to Meet the Minimum Bid Price Requirement	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/05/23	20:03	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/05/23	20:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/05/18	05:07	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/05/18	05:05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/05/01	21:45	PR Newswire (US)	KAZIA REPORTS SUCCESSFUL STAGE 1 COMPLETION OF THE EVT801 PHASE 1 CLINICAL TRIAL IN ADVANCED CANCER PATIENTS	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/03/21	21:52	PR Newswire (US)	Kazia Therapeutics licenses paxalisib to Sovargen for intractable seizures in rare central nervous system diseases	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/03/13	21:00	PR Newswire (US)	Kazia announces presentation of new data at AACR Annual Meeting	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/02/22	06:19	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/02/21	23:19	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/02/21	21:30	PR Newswire (US)	Kazia Therapeutics Reports Early Conclusion of Clinical Trial After Reaching Primary Endpoint	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/02/15	05:41	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/02/13	08:35	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/02/06	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/02/06	06:19	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/01/19	06:30	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/01/18	21:30	PR Newswire (US)	KAZIA CONTINUES BOARD RENEWAL WITH TWO NEW APPOINTMENTS	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/01/13	06:05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:KZIA	Kazia Therapeutics Ltd
2023/12/26	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:KZIA	Kazia Therapeutics Ltd
2023/12/16	07:26	Edgar (US Regulatory)	Form F-3 - Registration statement by foreign private issuers	NASDAQ:KZIA	Kazia Therapeutics Ltd
2023/12/16	06:49	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:KZIA	Kazia Therapeutics Ltd
2023/12/06	22:31	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:KZIA	Kazia Therapeutics Ltd
2023/12/06	08:02	PR Newswire (US)	Kazia Therapeutics Announces Closing of $2 Million Registered Direct Offering	NASDAQ:KZIA	Kazia Therapeutics Ltd
2023/12/05	06:05	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:KZIA	Kazia Therapeutics Ltd
2023/12/01	22:30	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:KZIA	Kazia Therapeutics Ltd
2023/12/01	22:00	PR Newswire (US)	Kazia Therapeutics Announces $2 Million Registered Direct Offering	NASDAQ:KZIA	Kazia Therapeutics Ltd
2023/11/30	06:19	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:KZIA	Kazia Therapeutics Ltd
2023/11/30	06:02	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:KZIA	Kazia Therapeutics Ltd
2023/11/29	21:01	PR Newswire (US)	KAZIA ANNOUNCES NON-BINDING LETTER OF INTENT FOR THE PROPOSED GRANTING OF RIGHTS TO DEVELOP AND COMMERCIALIZE PAXALISIB OUTSIDE OF ONCOLOGY	NASDAQ:KZIA	Kazia Therapeutics Ltd
2023/11/21	21:30	PR Newswire (US)	KAZIA PROVIDES OVERVIEW OF PAXALISIB RELATED PRESENTATIONS FROM THE SOCIETY OF NEURO-ONCOLOGY 2023 ANNUAL MEETING	NASDAQ:KZIA	Kazia Therapeutics Ltd

검색 관련기사 보기:NASDAQ:KZIA

1 2 3 4 5 6 7 8 9 10 다음 >>

Deutsche Telekom (QX)

JP Morgan Chase

US Dollar vs Sterling

BNP Paribas (QX)

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관